Skip to content

Study on an effect of continuous intake of a test food product on relieving a feeling of fatigue

Study on an effect of continuous intake of a test food product on relieving a feeling of fatigue - Study on an effect of continuous intake of a test food product on relieving a feeling of fatigue

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000030979
Enrollment
26
Registered
2018-01-29
Start date
2018-02-02
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy subjects

Interventions

Sponsors

HUMA R&D CORP
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Age: 30 and over, below 45 2)Sex: Males and females with Japanese nationality 3)No exercise habit in the last 12 months *Those who exercise once a week or less, or 2 to 3 times a month will be accepted.

Exclusion criteria

Exclusion criteria: 1)Currently in treatment with medication or seeing a doctor for treatment 2)Previous history of hepatic disorder or severe disorder related to kidney, endocrine, cardiovascular system, gastro-intestine, lung, blood, or metabolism, or currently presence of complications 3)Previous history of drug allergy or food allergy 4)Regular intake of a food product or a supplement with a possible effect on relieving fatigue 5)Regular intake of medication with a possible effect on relieving fatigue 6)Extreme faddiness 7)Extremely irregular lifestyle such as a dietary pattern and a sleeping pattern 8)Sleep disorder(insomnia, sleep apnea syndrome; SAS, etc.) 9)Presence or previous history of mental disorder (depression, etc.) 10)Presence or previous history of alcoholism 11)Current participation in another clinical trial or participation in another clinical trial within the last three months 12)Irregular work hours such as working on night shift 13)Exercise habit (twice a week or more) 14)Determined by the investigator to be unsuitable for enrollment in this study

Design outcomes

Primary

MeasureTime frame
VAS, Creatine kinase, Lactic acid

Secondary

MeasureTime frame
Hematologic test, blood biochemical test, vital signs

Countries

Japan

Contacts

Public ContactOchitani Daisuke

HUMA R&D CORP Clinical Development Division

ochitani@huma-c.co.jp81-3-3431-1260

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026